Science 37 Holdings, Inc.

NASDAQ
SNCE
paper.types.company
Rentabilité sur six mois: 0%
Rendement en dividendes: 0%
Secteur: Healthcare

5.75 $

0 $ 0%
5.75 $
5.75 $

paper.min_max_per_year

Calendrier des promotions Science 37 Holdings, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data.

plus de détails
The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
2020-11-20
ISIN
US8086441081
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 0.6789 10
P/BV 0.489 10
P/E 0 0
Efficacité
Nom Signification Grade
ROA -26.33 0
ROE -46.57 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.0093 10
Debt/Ratio 0.0103 10
Debt/Equity 0.2991 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 154.27 10
Rentabilité Ebitda, % 426.07 10
Rentabilité EPS, % 11478.95 10
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 5.75 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 5.75 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 5.75 $ 5.75 $ 5.75 $ 0 % 0 % 0 %
common.calendar.number_days.90d 5.75 $ 5.75 $ 5.75 $ 0 % 0 % 0 %
common.calendar.number_days.180d 5.75 $ 5.75 $ 5.75 $ 0 % 0 % 0 %
common.calendar.number_days.1y 5.75 $ 5.75 $ 5.75 $ 0 % 0 % 0 %
common.calendar.number_days.3y 3.24 $ 0.21 $ 103.2 $ 77.47 % 0 % 0 %
common.calendar.number_days.5y 0 $ 0.21 $ 103.2 $ 0 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.21 $ 103.2 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 5.75 $ 5.75 $ 5.75 $ 0 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. David Coman CEO & Director 796.13k 1970 (55 années)
Ms. Christine A. Pellizzari J.D. Chief Legal & Human Resources Officer and Secretary 521.58k 1968 (57 années)
Ms. Darcy Forman Chief Delivery Officer 550.58k 1976 (49 années)
Mr. Mike Zaranek Chief Financial Officer N/A 1971 (54 année)
Irena Lambridis VP and Head of Quality Assurance & Compliance N/A
Ms. Margie Gimbel Kooman Vice President of Marketing & Communications N/A
Mr. Drew Bustos Chief Strategy & Marketing Officer N/A
Mr. Jonathan Cotliar M.D. Chief Medical Officer 486.6k 1972 (53 année)
Mr. Michael Shipton Chief Commercial Officer N/A 1972 (53 année)
Mr. Tyler Van Horn VP of Corporate Strategy & Chief of Staff N/A

Informations sur l'entreprise

Adresse: United States, Research Triangle Park. NC, 800 Park Offices Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.science37.com